Literature DB >> 12843102

Cross-reactivity of the PLATELIA CANDIDA antigen detection enzyme immunoassay with fungal antigen extracts.

Dagmar Rimek1, Jagpal Singh, Reinhard Kappe.   

Abstract

We studied the specificity of the PLATELIA CANDIDA Ag enzyme immunoassay by using 130 isolates of 63 clinically relevant fungal species. Antigen extracts of seven Candida spp. (Candida albicans, C. dubliniensis, C. famata, C. glabrata, C. guilliermondii, C. lusitaniae, and C. tropicalis) repeatedly yielded positive reactions (>0.5 ng/ml). Geotrichum candidum and Fusarium verticillioides were found to yield borderline-positive reactions (0.25 to 0.50 ng/ml). Antigen preparations from the other 54 fungal species, including yeasts, molds, dermatophytes, and dimorphic fungi, did not cross-react in the assay.

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12843102      PMCID： PMC165363          DOI： 10.1128/JCM.41.7.3395-3398.2003

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  12 in total

1.  Bloodstream infections due to Candida species: SENTRY antimicrobial surveillance program in North America and Latin America, 1997-1998.

Authors:  M A Pfaller; R N Jones; G V Doern; H S Sader; S A Messer; A Houston; S Coffman; R J Hollis
Journal:  Antimicrob Agents Chemother       Date:  2000-03       Impact factor: 5.191

2.  Coexistence of free antigens, free antibodies and immune complexes in sera from patients with suspected deep-seated candidosis.

Authors:  R Kappe
Journal:  Mycoses       Date:  1989-01       Impact factor: 4.377

3.  New cause for false-positive results with the Pastorex Aspergillus antigen latex agglutination test.

Authors:  R Kappe; A Schulze-Berge
Journal:  J Clin Microbiol       Date:  1993-09       Impact factor: 5.948

Review 4.  Nonculture methods for diagnosis of disseminated candidiasis.

Authors:  E Reiss; C J Morrison
Journal:  Clin Microbiol Rev       Date:  1993-10       Impact factor: 26.132

5.  Combined detection of mannanaemia and antimannan antibodies as a strategy for the diagnosis of systemic infection caused by pathogenic Candida species.

Authors:  Boualem Sendid; Jean Louis Poirot; Marc Tabouret; Alain Bonnin; Denis Caillot; Daniel Camus; Daniel Poulain
Journal:  J Med Microbiol       Date:  2002-05       Impact factor: 2.472

Review 6.  Serologic response to cell wall mannoproteins and proteins of Candida albicans.

Authors:  J P Martínez; M L Gil; J L López-Ribot; W L Chaffin
Journal:  Clin Microbiol Rev       Date:  1998-01       Impact factor: 26.132

7.  International surveillance of blood stream infections due to Candida species in the European SENTRY Program: species distribution and antifungal susceptibility including the investigational triazole and echinocandin agents. SENTRY Participant Group (Europe).

Authors:  M A Pfaller; R N Jones; G V Doern; A C Fluit; J Verhoef; H S Sader; S A Messer; A Houston; S Coffman; R J Hollis
Journal:  Diagn Microbiol Infect Dis       Date:  1999-09       Impact factor: 2.803

8.  Contribution of serological tests and blood culture to the early diagnosis of systemic candidiasis.

Authors:  H Yera; B Sendid; N Francois; D Camus; D Poulain
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2001-12       Impact factor: 3.267

9.  Rapid clearance of Candida albicans mannan antigens by liver and spleen in contrast to prolonged circulation of Cryptococcus neoformans antigens.

Authors:  R Kappe; J Müller
Journal:  J Clin Microbiol       Date:  1991-08       Impact factor: 5.948

10.  Nature of Candida albicans-derived carbohydrate antigen recognized by a monoclonal antibody in patient sera and distribution over Candida species.

Authors:  P M Jacquinot; Y Plancke; B Sendid; G Strecker; D Poulain
Journal:  FEMS Microbiol Lett       Date:  1998-12-01       Impact factor: 2.742
View more
  7 in total

Review 1.  Surface glycans of Candida albicans and other pathogenic fungi: physiological roles, clinical uses, and experimental challenges.

Authors:  James Masuoka
Journal:  Clin Microbiol Rev       Date:  2004-04       Impact factor: 26.132

2.  Comparison of (1->3)-β-D-glucan, mannan/anti-mannan antibodies, and Cand-Tec Candida antigen as serum biomarkers for candidemia.

Authors:  Jürgen Held; Isabelle Kohlberger; Elfriede Rappold; Andrea Busse Grawitz; Georg Häcker
Journal:  J Clin Microbiol       Date:  2013-01-30       Impact factor: 5.948

3.  Diagnostic performance of 1→3-β-d-glucan in neonatal and pediatric patients with Candidemia.

Authors:  Maria Teresa Montagna; Caterina Coretti; Grazia Lovero; Osvalda De Giglio; Osvaldo Montagna; Nicola Laforgia; Nicola Santoro; Giuseppina Caggiano
Journal:  Int J Mol Sci       Date:  2011-09-14       Impact factor: 5.923

Review 4.  The use of mannan antigen and anti-mannan antibodies in the diagnosis of invasive candidiasis: recommendations from the Third European Conference on Infections in Leukemia.

Authors:  Malgorzata Mikulska; Thierry Calandra; Maurizio Sanguinetti; Daniel Poulain; Claudio Viscoli
Journal:  Crit Care       Date:  2010-12-08       Impact factor: 9.097

5.  A Retrospective Assessment of Four Antigen Assays for the Detection of Invasive Candidiasis Among High-Risk Hospitalized Patients.

Authors:  Barbara Hartl; Iris Zeller; Angelika Manhart; Brigitte Selitsch; Cornelia Lass-Flörl; Birgit Willinger
Journal:  Mycopathologia       Date:  2018-01-22       Impact factor: 2.574

6.  Characterization of a novel yeast phase-specific antigen expressed during in vitro thermal phase transition of Talaromyces marneffei.

Authors:  Kritsada Pruksaphon; Mc Millan Nicol Ching; Joshua D Nosanchuk; Anna Kaltsas; Kavi Ratanabanangkoon; Sittiruk Roytrakul; Luis R Martinez; Sirida Youngchim
Journal:  Sci Rep       Date:  2020-12-03       Impact factor: 4.379

Review 7.  Diagnosis of Fusarium Infections: Approaches to Identification by the Clinical Mycology Laboratory.

Authors:  Anne D van Diepeningen; Balázs Brankovics; Jearidienne Iltes; Theo A J van der Lee; Cees Waalwijk
Journal:  Curr Fungal Infect Rep       Date:  2015
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.